166 related articles for article (PubMed ID: 35901544)
1. Repurposing of the antihistamine mebhydrolin napadisylate for treatment of Zika virus infection.
Zhou R; Li Q; Yang B; Quan Y; Liu Y; Liu M; Zhang Y; Shan G; Li Z; Wang J; Li Y; Cen S
Bioorg Chem; 2022 Nov; 128():106024. PubMed ID: 35901544
[TBL] [Abstract][Full Text] [Related]
2. Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays.
Chen Y; Chi X; Zhang H; Zhang Y; Qiao L; Ding J; Han Y; Lin Y; Jiang J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768218
[TBL] [Abstract][Full Text] [Related]
3. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Bispecific Lead Compounds from
Kumar S; El-Kafrawy SA; Bharadwaj S; Maitra SS; Alandijany TA; Faizo AA; Khateb AM; Dwivedi VD; Azhar EI
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458761
[TBL] [Abstract][Full Text] [Related]
5. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus.
Yuan J; Yu J; Huang Y; He Z; Luo J; Wu Y; Zheng Y; Wu J; Zhu X; Wang H; Li M
BMC Med; 2020 Jul; 18(1):204. PubMed ID: 32731873
[TBL] [Abstract][Full Text] [Related]
7. A cell-based assay to discover inhibitors of Zika virus RNA-dependent RNA polymerase.
Wang L; Zhou R; Liu Y; Guo S; Yi D; Zhao J; Li Q; Zhang Y; Liang C; Wang J; Shan G; Cen S
Virology; 2024 Jan; 589():109939. PubMed ID: 37979208
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of the fused tricyclic derivatives of indoline and imidazolidinone on ZIKV infection and RdRp activities of ZIKV and DENV.
Zhou GF; Li F; Xue JX; Qian W; Gu XR; Zheng CB; Li C; Yang LM; Xiong SD; Zhou GC; Zheng YT
Virus Res; 2023 Mar; 326():199062. PubMed ID: 36746341
[TBL] [Abstract][Full Text] [Related]
9. Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor.
Zhou GF; Qian W; Li F; Yang RH; Wang N; Zheng CB; Li CY; Gu XR; Yang LM; Liu J; Xiong SD; Zhou GC; Zheng YT
Antiviral Res; 2023 Jun; 214():105607. PubMed ID: 37088168
[TBL] [Abstract][Full Text] [Related]
10. Dapoxetine, a Selective Serotonin Reuptake Inhibitor, Suppresses Zika Virus Infection In Vitro.
Zhang B; Yu J; Zhu G; Huang Y; Zhang K; Xiao X; He W; Yuan J; Gao X
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138628
[TBL] [Abstract][Full Text] [Related]
11. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking.
Tarannum H; Nandi S
Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069
[TBL] [Abstract][Full Text] [Related]
12. The in vitro and in vivo antiviral effects of aloperine against Zika virus infection.
Zhou P; Lao Z; Long H; Pan P; Liao F; Zheng W; Li Z; Dai J; Liu H; Jiang Y; Liu X; Wang W; Wu J; Li G
J Med Virol; 2023 Jul; 95(7):e28913. PubMed ID: 37409639
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of a series of new anthraquinone derivatives as anti-ZIKV agents.
Zhu Y; Yu J; Chen T; Liu W; Huang Y; Li J; Zhang B; Zhu G; He Z; Long Y; Yuan J
Eur J Med Chem; 2023 Oct; 258():115620. PubMed ID: 37421888
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of Doramectin as a New Anti-Zika Virus Agent.
Zhu Y; Liang M; Yu J; Zhang B; Zhu G; Huang Y; He Z; Yuan J
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243154
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine.
Sariyer IK; Gordon J; Burdo TH; Wollebo HS; Gianti E; Donadoni M; Bellizzi A; Cicalese S; Loomis R; Robinson JA; Carnevale V; Steiner J; Ozdener MH; Miller AD; Amini S; Klein ML; Khalili K
Mol Ther; 2019 Dec; 27(12):2067-2079. PubMed ID: 31653397
[TBL] [Abstract][Full Text] [Related]
16. The Screening of Phytochemicals Against NS5 Polymerase to Treat Zika Virus Infection: Integrated Computational Based Approach.
Rehman A; Ashfaq UA; Javed MR; Shahid F; Noor F; Aslam S
Comb Chem High Throughput Screen; 2022; 25(4):738-751. PubMed ID: 34254908
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures.
Elfiky AA; Ismail AM
SAR QSAR Environ Res; 2018 May; 29(5):409-418. PubMed ID: 29652194
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of Zika virus NS5 reveals conserved drug targets.
Duan W; Song H; Wang H; Chai Y; Su C; Qi J; Shi Y; Gao GF
EMBO J; 2017 Apr; 36(7):919-933. PubMed ID: 28254839
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Mechanism of Action of Anti-Dengue Compounds as Potential Binders of Zika Virus RNA-Dependent RNA Polymerase.
Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Alsaady IM; Altwaim SA; Dubey A; Dwivedi VD; Azhar EI
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515188
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
